Type 1 diabetes, also called juvenile diabetes, is a daily challenge in which patients face a not-so-simple lifestyle, are forced to stab themselves several times a day, monitor their sugar levels, count the amount of carbohydrates at each meal and decide on an appropriate insulin dose – so they are forced Make your own therapeutic decisions around the clock. However, an innovative development that has arrived in Israel can change the lives of diabetics. It is a new technology that makes therapeutic decisions independently, monitors and transmits the dose of insulin that the patient needs automatically 24/7. Want to know more? Watch the mako Facebook broadcast now.